New Hemophilia B Drug Wins FDA OK

(MedPage Today) -- SILVER SPRING, Md. -- A recombinant Factor IX protein drug (Alprolix) for hemophilia B that can be administered weekly or even less frequently has been approved by the FDA.

Source: MedPage Today Primary Care - March 28, 2014 Category: Primary Care Source Type: news